The plant, expected to create about 120 new jobs, will manufacture elastomer components used in injectable drug delivery systems.
Construction will start by the end of 2016, with production set to begin in early 2018.
Datwyler hopes the new plant will help strengthen its position in the global drug market.
More articles on supply chain:
Clinicians should take stock of patients, not shelves: 3 thoughts on supply chain’s role in patient care
Coastal hospitals prepare supplies for Hurricane Matthew
5 drugs awaiting FDA review in October
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
